Author details

Full Name

Laura Bergamaschi

Affiliation

ORCID

Career Start Year

2006

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
37302069	Proteomic analysis of circulating immune cells identifies cellular phenotypes associated with COVID-19 severity.	Cell Rep	2023
35508369	Y-radioembolisation in hepatocellular carcinoma induces immune responses calling for early treatment with multiple checkpoint blockers.	Gut	2023
37931331	Targeting NF-ÎºB signaling in B cells as a potential new treatment modality for ANCA-associated vasculitis.		2023
36717723	A patient-centric modeling framework captures recovery from SARS-CoV-2 infection.	Nat Immunol	2023
35224470	Coagulation factor V is a T-cell inhibitor expressed by leukocytes in COVID-19.	iScience	2022
34509614	Extracellular vesicles in anti-tumor immunity.	Seminars in Cancer Biology	2022
35143756	B cell receptor repertoire kinetics after SARS-CoV-2 infection and vaccination.	Cell Rep	2022
34299136	Molecular Determinants of Soft Tissue Sarcoma Immunity: Targets for Immune Intervention.	International Journal of Molecular Sciences	2021
34051148	Longitudinal analysis reveals that delayed bystander CD8+ TÂ cell activation and early immune pathology distinguish severe COVID-19 from mild disease.	Immunity	2021
33670598	Suppression of the HBP Function Increases Pancreatic Cancer Cell Sensitivity to a Pan-RAS Inhibitor.	Cells	2021
32793185	microRNAs Shape Myeloid Cell-Mediated Resistance to Cancer Immunotherapy.	Frontiers in Immunology	2020
33318491	Treatment of COVID-19 with remdesivir in the absence of humoral immunity: a case report.	Nat Commun	2020
32868930	Dynamic regulation of hypoxia-inducible factor-1Î± activity is essential for normal B cell development.	Nat Immunol	2020
28340352	Human Epistatic Interaction Controls IL7R Splicing and Increases Multiple Sclerosis Risk.	Cell	2017
24076602	Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis.	Nat Genet	2013
21833088	Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis.	Nature	2011
21441263	Association of HLA class I markers with multiple sclerosis in the Italian and UK population: evidence of two independent protective effects.	Journal of Medical Genetics	2011
21037273	Association of the CBLB gene with multiple sclerosis: new evidence from a replication study in an Italian population.	Journal of Medical Genetics	2011
19907433	HLA-class I markers and multiple sclerosis susceptibility in the Italian population.	Genes and Immunity	2010
20574445	A non-synonymous SNP within membrane metalloendopeptidase-like 1 (MMEL1) is associated with multiple sclerosis.	Genes Immun	2010
20116863	No evidence of association of the rare nsSNP rs35667974 in IFIH1 with multiple sclerosis.	Journal of Neuroimmunology	2010
20502484	Lack of support for association between the KIF1B rs10492972[C] variant and multiple sclerosis.	Nat Genet	2010
17928868	A sequence variation in the MOG gene is involved in multiple sclerosis susceptibility in Italy.	Genes and Immunity	2008
17462671	Variations in the coding and regulatory sequences of the angiogenin (ANG) gene are not associated to ALS (amyotrophic lateral sclerosis) in the Italian population.	Journal of the Neurological Sciences	2007
16952453	SOD1 gene mutations in Italian patients with Sporadic Amyotrophic Lateral Sclerosis (ALS).	Neuromuscular Disorders	2006